Summary
This prediction ended on 14.12.24 with a price of €570.00. With a performance of 51.60% the BUY prediction by BiotechBee was a big success. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Argenx SE | - | - | - |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% |
According to BiotechBee what are the pros and cons of Argenx SE for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Argenx SE diskutieren
Buy mit Kursziel 450,0